Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent Chemotherapy-Induced Thrombocytopenia By Ogkologos - March 26, 2026 81 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the RECITE study Source RELATED ARTICLESMORE FROM AUTHOR EMA Adopts a Positive Opinion for a New Route of Administration Together with a New Pharmaceutical Form and a New Strength for Isatuximab National Study Examines Genetic Testing to Inform Follow-up Care for Cancer Survivors Taletrectinib Demonstrates Durable Long-Term Efficacy in Both TKI-naïve and Crizotinib-pretreated Patients with Advanced ROS1-positive NSCLC MOST POPULAR FDA Approves Brentuximab Vedotin in Combination with Chemotherapy for Paediatric Patients... December 1, 2022 A New Era of Early Cancer Detection With Blood Test May... September 11, 2022 Building a Balanced Breakfast November 6, 2020 17 Old Fashioned Ways to Get Rid of Ants in Your... March 27, 2019 Load more HOT NEWS 2-Year-Boy Is So Excited To See Himself In Disney’s ‘Encanto’ On legacy giving: “It allows me to give something more meaningful... New study identifies how obesity may increase the risk of developing... New on NCI’s Websites for December 2020
